Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 74 articles:
HTML format
Text format



Single Articles


    May 2018
  1. LOFFLER MW, Kowalewski DJ, Backert L, Bernhardt J, et al
    Mapping the HLA ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation.
    Cancer Res. 2018 May 22. pii: 0008-5472.CAN-17-1745.
    PubMed     Text format     Abstract available


  2. ULLMANN P, Rodriguez F, Schmitz M, Meurer SK, et al
    The microRNA-371~373 cluster represses colon cancer initiation and metastatic colonization by inhibiting the TGFBR2/ID1 signaling axis.
    Cancer Res. 2018 May 10. pii: 0008-5472.CAN-17-3003.
    PubMed     Text format     Abstract available


    April 2018
  3. WANG Q, Zhou Y, Rychahou P, Harris JW, et al
    Deptor is a novel target of Wnt/beta-catenin/c-Myc and contributes to colorectal cancer cell growth.
    Cancer Res. 2018 Apr 17. pii: 0008-5472.CAN-17-3107.
    PubMed     Text format     Abstract available


    March 2018
  4. MENG Q, Wu S, Wang Y, Xu J, et al
    MPO promoter polymorphism rs2333227 enhances malignant phenotypes of colorectal cancer by altering the binding affinity of AP-2alpha.
    Cancer Res. 2018 Mar 14. pii: 0008-5472.CAN-17-2538.
    PubMed     Text format     Abstract available


  5. PAQUET-FIFIELD S, Koh SL, Cheng L, Beyit LM, et al
    Tight junction protein claudin-2 promotes self-renewal of human colorectal cancer stem-like cells.
    Cancer Res. 2018 Mar 6. pii: 0008-5472.CAN-17-1869.
    PubMed     Text format     Abstract available


    January 2018
  6. LIU L, Zhang Y, Wong CC, Zhang J, et al
    RNF6 promotes colorectal cancer by activating the Wnt/beta-catenin pathway via ubiquitination of TLE3.
    Cancer Res. 2018 Jan 26. pii: 0008-5472.CAN-17-2683.
    PubMed     Text format     Abstract available


  7. YAN TT, Ren LL, Shen CQ, Wang ZH, et al
    MicroRNA-508 defines the stem-like/mesenchymal subtype in colorectal cancer.
    Cancer Res. 2018 Jan 26. pii: 0008-5472.CAN-17-2101.
    PubMed     Text format     Abstract available


    December 2017
  8. HANKEY WC, McIlhatton MA, Ebede K, Kennedy B, et al
    Mutational mechanisms that activate Wnt signaling and predict outcomes in colorectal cancer patients.
    Cancer Res. 2017 Dec 6. pii: 0008-5472.CAN-17-1357.
    PubMed     Text format     Abstract available



  9. Correction: miR-103/107 Promote Metastasis of Colorectal Cancer by Targeting the Metastasis Suppressors DAPK and KLF4.
    Cancer Res. 2017;77:6788.
    PubMed     Text format    


  10. YAEGER R, Yao Z, Hyman DM, Hechtman JF, et al
    Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its Inhibition.
    Cancer Res. 2017;77:6513-6523.
    PubMed     Text format     Abstract available


    November 2017
  11. EMERSON MA, Banegas MP, Chawla N, Achacoso N, et al
    Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives.
    Cancer Res. 2017 Nov 29. pii: 0008-5472.CAN-17-0429.
    PubMed     Text format     Abstract available


  12. YAU EH, Kummetha IR, Lichinchi G, Tang R, et al
    Genome-Wide CRISPR Screen for Essential Cell Growth Mediators in Mutant KRAS Colorectal Cancers.
    Cancer Res. 2017;77:6330-6339.
    PubMed     Text format     Abstract available



  13. Correction: A Squalene-Based Nanomedicine for Oral Treatment of Colon Cancer.
    Cancer Res. 2017;77:6048.
    PubMed     Text format    


    October 2017
  14. LULLA AR, Slifker MJ, Zhou Y, Lev A, et al
    miR-6883 family miRNAs target CDK4/6 to induce G1 phase cell cycle arrest in colon cancer cells.
    Cancer Res. 2017 Oct 23. pii: canres.1767.2017.
    PubMed     Text format     Abstract available


  15. KIM SY, Jung JH, Lee HJ, Soh H, et al
    [18F]fluorothymidine positron emission tomography informs the synergistic efficacy of capecitabine and trifluridine/tipiracil in colon cancer.
    Cancer Res. 2017 Oct 20. pii: canres.1406.2017.
    PubMed     Text format     Abstract available


  16. HUANG S, Fantini D, Merrill B, Bagchi S, et al
    DDB2 is a Novel Regulator of Wnt-Signaling in Colon Cancer.
    Cancer Res. 2017 Oct 11. pii: canres.1570.2017.
    PubMed     Text format     Abstract available


  17. TANG YC, Yuwen H, Wang K, Bruno PM, et al
    Aneuploid Cell Survival Relies upon Sphingolipid Homeostasis.
    Cancer Res. 2017;77:5272-5286.
    PubMed     Text format     Abstract available


    September 2017
  18. KIDDER BL, He R, Wangsa D, Padilla-Nash HM, et al
    SMYD5 controls heterochromatin and chromosome integrity during embryonic stem cell differentiation.
    Cancer Res. 2017 Sep 26. pii: canres.0828.2017.
    PubMed     Text format     Abstract available


  19. ZHOU X, Geng L, Wang D, Yi H, et al
    R-Spondin1/LGR5 Activates TGFbeta Signaling and Suppresses Colon Cancer Metastasis.
    Cancer Res. 2017 Sep 22. pii: canres.0219.2017.
    PubMed     Text format     Abstract available


  20. KATHER JN, Poleszczuk J, Suarez-Carmona M, Krisam J, et al
    In silico modeling of immunotherapy and stroma-targeting therapies in human colorectal cancer.
    Cancer Res. 2017 Sep 18. pii: canres.2006.2017.
    PubMed     Text format     Abstract available


  21. LI P, Wuthrick E, Rappaport JA, Kraft C, et al
    GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.
    Cancer Res. 2017;77:5095-5106.
    PubMed     Text format     Abstract available


  22. TAKADA M, Zhang W, Suzuki A, Kuroda TS, et al
    FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis via Cyclin E1/CDK2-Mediated Phosphorylation of CENP-A.
    Cancer Res. 2017;77:4881-4893.
    PubMed     Text format     Abstract available


    August 2017
  23. JIN L, Vu T, Yuan G, Datta PK, et al
    STRAP promotes stemness of human colorectal cancer via epigenetic regulation of the NOTCH pathway.
    Cancer Res. 2017 Aug 21. pii: canres.0286.2017.
    PubMed     Text format     Abstract available


  24. ZHAO Y, Ting KK, Li J, Cogger VC, et al
    Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell-Mediated Immunotherapy.
    Cancer Res. 2017;77:4434-4447.
    PubMed     Text format     Abstract available


  25. MARELLI G, Erreni M, Anselmo A, Taverniti V, et al
    Heme-oxygenase-1 Production by Intestinal CX3CR1+ Macrophages Helps to Resolve Inflammation and Prevents Carcinogenesis.
    Cancer Res. 2017;77:4472-4485.
    PubMed     Text format     Abstract available


    July 2017
  26. JERMYN M, Mercier J, Aubertin K, Desroches J, et al
    Highly Accurate Detection of Cancer In Situ with Intraoperative, Label-Free, Multimodal Optical Spectroscopy.
    Cancer Res. 2017;77:3942-3950.
    PubMed     Text format     Abstract available


    June 2017
  27. HOU PC, Li YH, Lin SC, Lin SC, et al
    Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness.
    Cancer Res. 2017 Jun 26. pii: canres.2990.2016.
    PubMed     Text format     Abstract available


  28. KONDELIN J, Gylfe AE, Lundgren S, Tanskanen T, et al
    Comprehensive evaluation of protein coding mononucleotide microsatellites in microsatellite-unstable colorectal cancer.
    Cancer Res. 2017 Jun 13. pii: canres.0682.2017.
    PubMed     Text format     Abstract available


  29. YOKOYAMA Y, Watanabe T, Tamura Y, Hashizume Y, et al
    Autocrine BMP-4 signaling is a therapeutic target in colorectal cancer.
    Cancer Res. 2017 Jun 13. pii: canres.0112.2017.
    PubMed     Text format     Abstract available


    May 2017
  30. KLOOSTERMAN WP, Coebergh van den Braak RRJ, Pieterse M, van Roosmalen MJ, et al
    A systematic analysis of oncogenic gene fusions in primary colon cancer.
    Cancer Res. 2017 May 16. pii: canres.3563.2017.
    PubMed     Text format     Abstract available


  31. TOMKOVICH S, Yang Y, Winglee K, Gauthier J, et al
    Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis.
    Cancer Res. 2017;77:2620-2632.
    PubMed     Text format     Abstract available


  32. VISWANATHAN V, Damle S, Zhang T, Opdenaker LM, et al
    An miRNA expression signature for the human colonic stem cell niche distinguishes malignant from normal epithelia.
    Cancer Res. 2017 May 9. pii: canres.2388.2016.
    PubMed     Text format     Abstract available


  33. LANG M, Berry D, Passecker K, Mesteri I, et al
    HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis.
    Cancer Res. 2017;77:2424-2438.
    PubMed     Text format     Abstract available


    April 2017
  34. WANG D, Sun H, Wei J, Cen B, et al
    CXCL1 is critical for pre-metastatic niche formation and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 28. pii: canres.3199.2016.
    PubMed     Text format     Abstract available


  35. HUANG B, Yang H, Cheng X, Wang D, et al
    tRF/miR-1280 suppresses stem cell-like cells and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 26. pii: canres.3146.2016.
    PubMed     Text format     Abstract available


  36. KOTELEVETS L, Chastre E, Caron J, Mougin J, et al
    A squalene-based nanomedicine for oral treatment of colon cancer.
    Cancer Res. 2017 Apr 17. pii: canres.1741.2016.
    PubMed     Text format     Abstract available


  37. NIMANONG S, Ostroumov D, Wingerath J, Knocke S, et al
    CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations.
    Cancer Res. 2017;77:1918-1926.
    PubMed     Text format     Abstract available


  38. EDUATI F, Doldan-Martelli V, Klinger B, Cokelaer T, et al
    Drug resistance mechanisms in colorectal cancer dissected with cell type-specific dynamic logic models.
    Cancer Res. 2017 Apr 5. pii: canres.0078.2017.
    PubMed     Text format     Abstract available


    March 2017
  39. HSIAO KY, Lin YC, Gupta SK, Chang N, et al
    Non-coding effects of circular RNA CCDC66 promote colon cancer growth and metastasis.
    Cancer Res. 2017 Mar 1. pii: canres.1883.2016.
    PubMed     Text format     Abstract available


  40. TIE G, Yan J, Khair L, Messina J, et al
    Hypercholesterolemia increases colorectal cancer incidence by reducing production of NKT and gammadelta T cells from hematopoietic stem cells.
    Cancer Res. 2017 Mar 1. pii: canres.1916.2016.
    PubMed     Text format     Abstract available


  41. QIAO G, Qin J, Kunda N, Calata J, et al
    LIGHT elevation enhances immune eradication of colon cancer metastases.
    Cancer Res. 2017 Mar 1. pii: canres.1655.2016.
    PubMed     Text format     Abstract available


  42. FANG M, Li Y, Huang K, Qi S, et al
    IL-33 promotes colon cancer cell stemness via JNK activation and macrophage recruitment.
    Cancer Res. 2017 Mar 1. pii: canres.1602.2016.
    PubMed     Text format     Abstract available


  43. MAHNE AE, Mauze S, Joyce-Shaikh B, Xia J, et al
    Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy.
    Cancer Res. 2017;77:1108-1118.
    PubMed     Text format     Abstract available


    February 2017
  44. BLAJ C, Schmidt EM, Lamprecht S, Hermeking H, et al
    Oncogenic effects of high MAPK activity in colorectal cancer mark progenitor cells and persist irrespective of RAS mutations.
    Cancer Res. 2017 Feb 15. pii: canres.2821.2016.
    PubMed     Text format     Abstract available


  45. TONG J, Wang P, Tan S, Chen D, et al
    Mcl-1 degradation is required for targeted therapeutics to eradicate colon cancer cells.
    Cancer Res. 2017 Feb 15. pii: canres.3242.2016.
    PubMed     Text format     Abstract available


    January 2017
  46. ROKAVEC M, Hermeking H
    Cellular model of colon cancer progression reveals signatures of mRNAs, miRNA, lncRNAs and epigenetic modifications associated with metastasis.
    Cancer Res. 2017 Jan 27. pii: canres.3236.2016.
    PubMed     Text format     Abstract available


  47. MATHOT L, Kundu S, Ljungstrom V, Svedlund J, et al
    Somatic ephrin receptor mutations are associated with metastasis in primary colorectal cancer.
    Cancer Res. 2017 Jan 20. pii: canres.1921.2016.
    PubMed     Text format     Abstract available


  48. REYNAUD C, Ferreras L, Di Mauro P, Kan C, et al
    Lysyl Oxidase Is a Strong Determinant of Tumor Cell Colonization in Bone.
    Cancer Res. 2017;77:268-278.
    PubMed     Text format     Abstract available


  49. VIENNOIS E, Merlin D, Gewirtz AT, Chassaing B, et al
    Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis.
    Cancer Res. 2017;77:27-40.
    PubMed     Text format     Abstract available


  50. KANG DW, Lee SW, Hwang WC, Lee BH, et al
    Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells.
    Cancer Res. 2017;77:142-152.
    PubMed     Text format     Abstract available


  51. TIAN X, Nguyen M, Foote HP, Caster JM, et al
    CRLX101, a Nanoparticle-Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1alpha.
    Cancer Res. 2017;77:112-122.
    PubMed     Text format     Abstract available


    November 2016
  52. CEJAS P, Cavazza A, Yandava C, Moreno V, et al
    Transcriptional regulator CNOT3 defines an aggressive colorectal cancer subtype.
    Cancer Res. 2016 Nov 29. pii: canres.1346.2016.
    PubMed     Text format     Abstract available


  53. USHIJIMA T, Yoshino T
    The Moment that KRAS Mutation Started to Evolve into Precision Medicine in Metastatic Colorectal Cancer.
    Cancer Res. 2016;76:6443-6444.
    PubMed     Text format    


    October 2016
  54. ZHANG M, Xu C, Wen L, Han MK, et al
    A hyaluronidase responsive nanoparticle-based drug delivery system for targeting colon cancer cells.
    Cancer Res. 2016 Oct 14. pii: canres.1681.2016.
    PubMed     Text format     Abstract available


  55. ESSIEN BE, Sundaresan S, Ocadiz-Ruiz R, Chavis A, et al
    Transcription factor ZBP-89 drives a feedforward loop of beta-catenin expression in colorectal cancer.
    Cancer Res. 2016 Oct 10. pii: canres.3150.2015.
    PubMed     Text format     Abstract available


    September 2016
  56. HORN T, Ferretti S, Ebel N, Tam A, et al
    High order drug combinations are required to effectively kill colorectal cancer cells.
    Cancer Res. 2016 Sep 22. pii: canres.3425.2015.
    PubMed     Text format     Abstract available


    August 2016
  57. DI CECILIA S, Zhang F, Sancho-Medina A, Li S, et al
    RBM-AS1 is critical for self-renewal of colon cancer stem-like cells.
    Cancer Res. 2016 Aug 12. pii: canres.1824.2015.
    PubMed     Text format     Abstract available


  58. LIMAGNE E, Euvrard R, Thibaudin M, Rebe C, et al
    Accumulation of MDSC and Th17 cells in patients with metastatic colorectal cancer predict the efficacy of a FOLFOX-bevacizumab drug treatment regimen.
    Cancer Res. 2016 Aug 5. pii: canres.3164.2015.
    PubMed     Text format     Abstract available


  59. BENJAMIN LE
    Commentary on "KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer".
    Cancer Res. 2016;76:4309-10.
    PubMed     Text format    


    July 2016
  60. DE LA CHAPELLE A
    Colon Cancer Germline Genetics: The Unbelievable Year 1993 and Thereafter.
    Cancer Res. 2016;76:4025-7.
    PubMed     Text format    


    June 2016
  61. SU L, Luo Y, Yang Z, Yang J, et al
    MEF2D transduces microenvironment stimuli to ZEB1 to promote epithelial-mesenchymal transition and metastasis in colorectal cancer.
    Cancer Res. 2016 Jun 30. pii: canres.0246.2016.
    PubMed     Text format     Abstract available


  62. KUO WT, Lee TC, Yu LC
    Eritoran suppresses colon cancer by altering a functional balance in Toll-like receptors that bind lipopolysaccharide.
    Cancer Res. 2016 Jun 21. pii: canres.0172.2016.
    PubMed     Text format     Abstract available


  63. ODDO D, Sennott EM, Barault L, Valtorta E, et al
    Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer.
    Cancer Res. 2016 Jun 16. pii: canres.0396.2016.
    PubMed     Text format     Abstract available


    May 2016
  64. ALEKSANDROVA K, Giuseppe RD, Isermann B, Biemann R, et al
    Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC - Potsdam Cohort Study.
    Cancer Res. 2016 May 23. pii: canres.3464.2015.
    PubMed     Text format     Abstract available


  65. ZHOU J, Wang H, Zhang H, Lutz AM, et al
    VEGFR2-targeted three-dimensional ultrasound imaging can predict responses to anti-angiogenic therapy in preclinical models of colon cancer.
    Cancer Res. 2016 May 20. pii: canres.3271.2015.
    PubMed     Text format     Abstract available


  66. GIRAUD J, Failla LM, Pascussi JM, Lagerqvist EL, et al
    Autocrine secretion of progastrin promotes the survival and self-renewal of colon cancer stem-like cells.
    Cancer Res. 2016 May 4. pii: canres.1497.2015.
    PubMed     Text format     Abstract available


    April 2016
  67. FEHRINGER G, Kraft P, Pharoah PD, Eeles RA, et al
    Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.
    Cancer Res. 2016 Apr 20. pii: canres.2980.2015.
    PubMed     Text format     Abstract available


  68. HOUSSEAU F, Wu S, Wick EC, Fan H, et al
    Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis.
    Cancer Res. 2016;76:2115-24.
    PubMed     Text format     Abstract available


  69. SRINIVASAN T, Walters J, Bu P, Than EB, et al
    NOTCH Signaling Regulates Asymmetric Cell Fate of Fast- and Slow-Cycling Colon Cancer Initiating Cells.
    Cancer Res. 2016 Apr 11. pii: canres.3198.2015.
    PubMed     Text format     Abstract available


    March 2016
  70. RAYNAL NJ, Lee JT, Wang Y, Beaudry A, et al
    Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer.
    Cancer Res. 2016;76:1494-505.
    PubMed     Text format     Abstract available


    February 2016
  71. RAO CV, Sanghera S, Zhang Y, Biddick L, et al
    Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1-/+ Mice.
    Cancer Res. 2016;76:630-42.
    PubMed     Text format     Abstract available


  72. MARUSIAK AA, Stephenson NL, Baik H, Trotter EW, et al
    Recurrent MLK4 Loss-of-Function Mutations Suppress JNK Signaling to Promote Colon Tumorigenesis.
    Cancer Res. 2016;76:724-35.
    PubMed     Text format     Abstract available


    January 2016
  73. XING C, Lu XX, Guo PD, Shen T, et al
    Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis.
    Cancer Res. 2016;76:83-95.
    PubMed     Text format     Abstract available


  74. TAVARE R, Escuin-Ordinas H, Mok S, McCracken MN, et al
    An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.
    Cancer Res. 2016;76:73-82.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: